Research & Development

A Long-Term Commitment to Health Innovation

At Hovid, we understand that the battle against diseases is an ongoing challenge. We believe that passion drives every breakthrough, empowering us to push the boundaries of healthcare services. Innovation is at the heart of our mission to develop new, patented formulations that contribute to the prevention and treatment of diseases.

Fighting to Improve People’s Health

Professional Scientists & Laboratory Executives

Bioequivalence (BE) Studies completed

Products in the R&D Pipeline

Clinical Trials

Our Qualified Facilities

Tailored to Meet Customer Needs

Hovid’s R&D division, known as Attest Research Sdn Bhd, focuses on stability and bioequivalence (BE) studies—critical for ensuring the quality and consistency of our products. Recognized by the Ministry of Health Malaysia as one of the few centers authorized to conduct BE studies, we ensure that all Hovid products meet the highest levels of quality, efficacy, and safety.

To meet the increasing demand for BE studies, we have established a large, advanced facility in Bayan Lepas, Penang, equipped with cutting-edge clinical technologies. This facility also provides a comfortable environment for volunteers participating in our studies. Additionally, another dedicated R&D team operates from our manufacturing plant in Chemor, Perak, further supporting and driving these essential studies.

What we do

Product Development

Product Development

  • Solid, semi-solid and liquid oral dosage forms
  • Topical preparations, including emulsions, suspensions, creams and ointments
  • Soft gelatin preparations

Drug Delivery System Innovation

Drug Delivery System Innovation

  • Controlled-release formulations
  • Enhanced oral bioavailability formulations

Stability Studies & Testing

Stability Studies & Testing

  • 25°C ± 2°C / 60% ± 5% RH
  • 30°C ± 2°C / 75% ± 5% RH
  • 40°C ± 2°C / 75% ± 5% RH

Clinical Services

Clinical Services

  • Bioequivalance (BE) studies
  • Bioavailability (BA) studies
  • Efficacy studies

First “6” Achievements in Malaysia

First to develop a commercial process for extracting Palm Tocotrienols

First to develop a self-emulsifying SupraBioTM system

First to have a soft gelatin encapsulation plant

First to produce film-coated analgesics, softgel capsules & effervescent tablets

First to produce antibiotics in dispersible tablet form

First to develop patented technologies in drug delivery systems

Search
×